BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33850265)

  • 1. SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma.
    Venugopalan A; Lynberg M; Cultraro CM; Nguyen KDP; Zhang X; Waris M; Dayal N; Abebe A; Maity TK; Guha U
    Oncogene; 2021 May; 40(18):3331-3346. PubMed ID: 33850265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of selected secretory carrier membrane proteins, SCAMP1 and SCAMP3, and association with the EGF receptor.
    Wu TT; Castle JD
    Mol Biol Cell; 1998 Jul; 9(7):1661-74. PubMed ID: 9658162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of MIG6 Accelerates Initiation and Progression of Mutant Epidermal Growth Factor Receptor-Driven Lung Adenocarcinoma.
    Maity TK; Venugopalan A; Linnoila I; Cultraro CM; Giannakou A; Nemati R; Zhang X; Webster JD; Ritt D; Ghosal S; Hoschuetzky H; Simpson RM; Biswas R; Politi K; Morrison DK; Varmus HE; Guha U
    Cancer Discov; 2015 May; 5(5):534-49. PubMed ID: 25735773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics.
    Zhang X; Belkina N; Jacob HK; Maity T; Biswas R; Venugopalan A; Shaw PG; Kim MS; Chaerkady R; Pandey A; Guha U
    Proteomics; 2015 Jan; 15(2-3):340-55. PubMed ID: 25404012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCAMP3 negatively regulates epidermal growth factor receptor degradation and promotes receptor recycling.
    Aoh QL; Castle AM; Hubbard CH; Katsumata O; Castle JD
    Mol Biol Cell; 2009 Mar; 20(6):1816-32. PubMed ID: 19158374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways.
    Acevedo-Díaz A; Morales-Cabán BM; Zayas-Santiago A; Martínez-Montemayor MM; Suárez-Arroyo IJ
    Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82.
    Yang CH; Chou HC; Fu YN; Yeh CL; Cheng HW; Chang IC; Liu KJ; Chang GC; Tsai TF; Tsai SF; Liu HP; Wu YC; Chen YT; Huang SF; Chen YR
    Biochim Biophys Acta; 2015 Jul; 1852(7):1540-9. PubMed ID: 25912735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant large tumor suppressor 2 (LATS2) gene expression correlates with EGFR mutation and survival in lung adenocarcinomas.
    Luo SY; Sit KY; Sihoe AD; Suen WS; Au WK; Tang X; Ma ES; Chan WK; Wistuba II; Minna JD; Tsao GS; Lam DC
    Lung Cancer; 2014 Aug; 85(2):282-92. PubMed ID: 24976335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells.
    Sutton P; Borgia JA; Bonomi P; Plate JM
    Mol Cancer; 2013 Jul; 12():76. PubMed ID: 23866081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARF promotes the degradation of the Epidermal Growth Factor Receptor by the lysosome.
    Beaumont A; Dayde D; Hatat AS; Barrial C; Perron P; Eymin B; Gazzeri S
    Exp Cell Res; 2018 Sep; 370(2):264-272. PubMed ID: 29959911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoke induces aberrant EGF receptor activation that mediates lung cancer development and resistance to tyrosine kinase inhibitors.
    Filosto S; Becker CR; Goldkorn T
    Mol Cancer Ther; 2012 Apr; 11(4):795-804. PubMed ID: 22302097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma.
    Kang DH; Jung SS; Yeo MK; Lee DH; Yoo G; Cho SY; Oh IJ; Kim JO; Park HS; Chung C; Lee JE
    BMC Cancer; 2020 Jun; 20(1):571. PubMed ID: 32552717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Shp2 suppresses mutant EGFR-induced lung tumors in transgenic mouse model of lung adenocarcinoma.
    Schneeberger VE; Ren Y; Luetteke N; Huang Q; Chen L; Lawrence HR; Lawrence NJ; Haura EB; Koomen JM; Coppola D; Wu J
    Oncotarget; 2015 Mar; 6(8):6191-202. PubMed ID: 25730908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of Mig6 negatively regulates the ubiquitination and degradation of EGFR mutants in lung adenocarcinoma cell lines.
    Boopathy GTK; Lynn JLS; Wee S; Gunaratne J; Hong W
    Cell Signal; 2018 Mar; 43():21-31. PubMed ID: 29196224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory Carrier Membrane Protein 3 Interacts with 3A Viral Protein of Enterovirus and Participates in Viral Replication.
    Lu JY; Brewer G; Li ML; Lin KZ; Huang CC; Yen LC; Lin JY
    Microbiol Spectr; 2021 Sep; 9(1):e0047521. PubMed ID: 34378951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
    Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
    J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.
    Hong SY; Kao YR; Lee TC; Wu CW
    Cancer Res; 2018 Sep; 78(17):4984-4996. PubMed ID: 29945960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR-MAPK p38 signaling pathway.
    Kang L; Zhang ZH; Zhao Y
    Am J Transl Res; 2020; 12(12):7870-7884. PubMed ID: 33437366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCAMP3 Promotes Glioma Proliferation and Indicates Unfavorable Prognosis via Multiple Pathways.
    Li C; Zhang Z; Lv P; Zhan Y; Zhong Q
    Onco Targets Ther; 2020; 13():3677-3687. PubMed ID: 32431518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERBB3-independent activation of the PI3K pathway in EGFR-mutant lung adenocarcinomas.
    Song X; Fan PD; Bantikassegn A; Guha U; Threadgill DW; Varmus H; Politi K
    Cancer Res; 2015 Mar; 75(6):1035-45. PubMed ID: 25596284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.